390 related articles for article (PubMed ID: 17069818)
1. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
[TBL] [Abstract][Full Text] [Related]
2. Impact of a combined treatment of angiotensin II type 1 receptor blockade and 3-hydroxy-3-methyl-glutaryl-CoA-reductase inhibition on secretory phospholipase A2-type IIA and low density lipoprotein oxidation in patients with coronary artery disease.
Divchev D; Grothusen C; Luchtefeld M; Thoenes M; Onono F; Koch R; Drexler H; Schieffer B
Eur Heart J; 2008 Aug; 29(16):1956-65. PubMed ID: 18565968
[TBL] [Abstract][Full Text] [Related]
3. The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?
Divchev D; Schieffer B
Vasc Health Risk Manag; 2008; 4(3):597-604. PubMed ID: 18827909
[TBL] [Abstract][Full Text] [Related]
4. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
[TBL] [Abstract][Full Text] [Related]
5. sPLA2-IIA Augments Oxidized LDL-Induced MCP-1 Expression in Vitro Through Activation of Akt.
Guo Y; Li B; Xu X; Wu R; Li W
Cell Physiol Biochem; 2015; 37(4):1345-54. PubMed ID: 26488172
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress: the EPAS trial.
Morawietz H; Erbs S; Holtz J; Schubert A; Krekler M; Goettsch W; Kuss O; Adams V; Lenk K; Mohr FW; Schuler G; Hambrecht R
Circulation; 2006 Jul; 114(1 Suppl):I296-301. PubMed ID: 16820589
[TBL] [Abstract][Full Text] [Related]
8. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease.
Schieffer B; Bünte C; Witte J; Hoeper K; Böger RH; Schwedhelm E; Drexler H
J Am Coll Cardiol; 2004 Jul; 44(2):362-8. PubMed ID: 15261932
[TBL] [Abstract][Full Text] [Related]
10. Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism.
Blache D; Gautier T; Tietge UJ; Lagrost L
FASEB J; 2012 Feb; 26(2):927-37. PubMed ID: 22042222
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X.
Pruzanski W; Kopilov J; Kuksis A
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():64-8. PubMed ID: 26711221
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium.
Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L
Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014
[TBL] [Abstract][Full Text] [Related]
13. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.
Bai X; Wang S; Shu L; Cao Q; Hu H; Zhu Y; Chen C
J Ethnopharmacol; 2024 Jun; 327():118006. PubMed ID: 38442806
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.
Ghesquiere SA; Gijbels MJ; Anthonsen M; van Gorp PJ; van der Made I; Johansen B; Hofker MH; de Winther MP
J Lipid Res; 2005 Feb; 46(2):201-10. PubMed ID: 15576846
[TBL] [Abstract][Full Text] [Related]
15. [Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease].
Pirkova AA; Samoĭlova EV; Ameliushkina VA; Kaminnyĭ AI; Titov VN; Prokazova NV; Naumov VG; Kucharchuk VV; Korotaeva AA
Kardiologiia; 2007; 47(4):37-40. PubMed ID: 18260836
[TBL] [Abstract][Full Text] [Related]
16. Effects of Statins and Xuezhikang on the Expression of Secretory Phospholipase A2, Group IIA in Rat Vascular Smooth Muscle Cells.
Xie Q; Zhang D
Int Heart J; 2017 Feb; 58(1):115-124. PubMed ID: 28123160
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K
Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin AT1 receptor blockers suppress oxidized low-density lipoprotein-derived formation of foam cells.
Osada-Oka M; Kita H; Yagi S; Sato T; Izumi Y; Iwao H
Eur J Pharmacol; 2012 Mar; 679(1-3):9-15. PubMed ID: 22265725
[TBL] [Abstract][Full Text] [Related]
19. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells.
Jaulmes A; Janvier B; Andreani M; Raymondjean M
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1161-7. PubMed ID: 15802623
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
